| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/12/2013 | CN103145809A Method for preparing anidulafungin |
| 06/12/2013 | CN103145808A Antigen mimic epitope of ochratoxin A and application thereof |
| 06/12/2013 | CN103145807A Hepatitis C virus (HCV) B-cell epitope peptide PUHI37 and application thereof |
| 06/12/2013 | CN103145806A Hepatitis C virus (HCV) B-cell epitope peptide PUHI26 and application thereof |
| 06/12/2013 | CN103145805A Heterozygosis antimicrobial peptide Lfcin-P-CecropinB (LPCB) and preparation method thereof |
| 06/12/2013 | CN103145804A Porcine parvovirus VP2 affinity peptide and coding nucleotide thereof |
| 06/12/2013 | CN103145803A Polypeptide in specific binding with breast cancer brain metastases cells |
| 06/12/2013 | CN103145802A Polypeptide infection promoting agent |
| 06/12/2013 | CN103145801A Anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide from MTA1 (Tumor Metastasis Associated Antigen 1) and application thereof |
| 06/12/2013 | CN103145800A Centipede zymolyte anti-thrombus polypeptide |
| 06/12/2013 | CN103145799A Group of polypeptides having percutaneous and transmembrane penetration promoting effect, and applications thereof |
| 06/12/2013 | CN103145798A Polypeptide of specific binding rare earth nanoparticle and screening method thereof |
| 06/12/2013 | CN103145797A [(3s)-1,2,3,4-tetrahydroisoquinoline-3-formoxy]-Lys modified RGD tetrapeptide and its synthesis method and use in medical science |
| 06/12/2013 | CN102603870B Taste peptide as well as preparation method and application thereof |
| 06/12/2013 | CN102399267B Gene vector modified by bifunctional peptide and preparation method thereof |
| 06/12/2013 | CN101993476B Casein active single peptide as well as preparation method and application thereof |
| 06/12/2013 | CN101914135B Broad-spectrum chemokine receptor antagonistic polypeptide and application thereof |
| 06/12/2013 | CN101307106B Endothelial cell proliferation inhibitor and method of use |
| 06/11/2013 | US8461299 Peptide capable of binding to immunoglobulin |
| 06/11/2013 | US8461298 Compositions and methods for modification of biomolecules |
| 06/11/2013 | US8461119 Peptides, peptidomimetics; promoting programmed cell death; neural regeneration |
| 06/11/2013 | US8460697 Pro-angiogenic peptides and uses thereof |
| 06/11/2013 | US8460674 HSV-1 epitopes and methods for using same |
| 06/11/2013 | CA2469336C Guanidinium transport reagents and conjugates |
| 06/11/2013 | CA2426012C Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements |
| 06/11/2013 | CA2400410C Antimicrobial compounds and formulations |
| 06/11/2013 | CA2388461C Highly conserved genes and their use to generate probes and primers for the detection of microorganisms |
| 06/11/2013 | CA2267664C Human telomerase reverse transcriptase |
| 06/06/2013 | WO2013082308A1 Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support |
| 06/06/2013 | WO2013081037A1 IgA-BINDING PEPTIDE AND PURIFICATION OF IgA THEREBY |
| 06/06/2013 | WO2012101601A9 Glycogen synthase kinase-3 inhibitors |
| 06/06/2013 | WO2012101599A9 Glycogen synthase kinase-3 inhibitors |
| 06/06/2013 | US20130144037 Novel lipid peptide and hydrogel |
| 06/06/2013 | US20130143824 Compositions and methods for enhancing apoptosis |
| 06/06/2013 | US20130143823 Compositions and methods of inhibiting apoptosis |
| 06/06/2013 | US20130143822 Agents for treating alzheimer's disease |
| 06/06/2013 | US20130143809 Neurotrophic peptides |
| 06/06/2013 | US20130143791 Peptides as active agents to stabilize biological barriers |
| 06/06/2013 | US20130143296 Delivery System for Cytotoxic Drugs by Bispecific Antibody Pretargeting |
| 06/06/2013 | US20130143294 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 06/06/2013 | US20130142867 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis |
| 06/06/2013 | US20130142764 Methods and compositions for treating brain diseases |
| 06/05/2013 | EP2599788A1 Angiogenesis-inhibiting peptide and application thereof |
| 06/05/2013 | EP2598519A1 Anti-viral agent |
| 06/05/2013 | EP2598518A1 Pre-polymer preparations for cell culture coatings |
| 06/05/2013 | EP2598157A1 Cyclic peptides, their preparation and their use as inhibitors of the platelet adhesion |
| 06/05/2013 | CN202968436U Purification device of enramycin |
| 06/05/2013 | CN103140512A Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof |
| 06/05/2013 | CN103130876A Preparing method of high-purity polymyxin B |
| 06/05/2013 | CN103130875A Method for extracting polymyxin B from fermentation broth |
| 06/05/2013 | CN103130874A Preparation method of high purity ramoplanin |
| 06/05/2013 | CN103130873A Antituberculous CTL (Cytotoxic T Lymphocyte) epitope peptide with drug-resistant related efflux protein source for tuberculosis and application of epitope peptide |
| 06/05/2013 | CN103130872A Adsorbent, solid phase carrier and purification method |
| 06/05/2013 | CN102311486B Method for separating and extracting enramycin by using macroporous weakly-acidic cationic resin |
| 06/05/2013 | CN102268073B Method for preparing somatostatin |
| 06/05/2013 | CN102234315B Modified endomorphin-1 compound and application in easing pain thereof |
| 06/05/2013 | CN102212113B Tuberculosis medicament resistance related tuberculosis-resisting cytotoxic T lymphocyte (CTL) epitope peptide derived from refflux protein and application thereof |
| 06/05/2013 | CN102212112B MTA1 (metastasis-associated gene 1)-derived anti-tumor CTL (cytotoxic T lymphocyte) epitope peptide and application thereof |
| 06/05/2013 | CN102180950B Human-derived voltage-gated potassium channel 1.3 immunogenic peptide fragment and application thereof |
| 06/05/2013 | CN102167723B Preparation method of polypeptide synthesis carbetocin |
| 06/05/2013 | CN101883781B 7P peptide and its derivant, the use thereof |
| 06/05/2013 | CN101863964B Helicobacter pylori urease B antigen epitope polypeptide and application thereof |
| 06/05/2013 | CN101759777B Method for synthesizing goserelin |
| 06/05/2013 | CN101631801B Receptor (SSTR2)-selective somatostatin antagonists |
| 06/05/2013 | CN101389641B Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae |
| 06/05/2013 | CN101031583B Antimicrobial peptides containing arginine and/or lysine motif |
| 06/04/2013 | US8455450 Methods for obtaining a therapeutically effective amount of hematopoietic precursor cells and long term engraftment thereof |
| 06/04/2013 | US8455449 Compositions and methods for modulating γ-c-cytokine activity |
| 06/04/2013 | US8455447 Modified therapeutic agents |
| 06/04/2013 | US8455444 CDH3 peptide and medicinal agent comprising the same |
| 06/04/2013 | US8455442 Peptides having binding affinity to an antibody which recognizes an epitope on an α1 loop 2 or β2 loop 1 of an adrenoreceptor |
| 06/04/2013 | US8454976 Recombinant toxin fragments |
| 06/04/2013 | CA2702470C Functional lipid constructs |
| 06/04/2013 | CA2439178C Template-fixed peptidomimetics with antimicrobial activity |
| 05/30/2013 | WO2013077680A1 Development of novel macromolecule transduction domain with improved cell permeability and method for using same |
| 05/30/2013 | WO2013076666A1 Antimicrobial peptides and uses thereof |
| 05/30/2013 | WO2013075244A1 Peptide sequence design and use thereof for peptide-mediated sirna delivery |
| 05/30/2013 | WO2013034982A3 Immunomodulatory peptides for treatment of progressive neurodegenerative diseases |
| 05/30/2013 | WO2012158962A3 Improved peptide pharmaceuticals |
| 05/30/2013 | US20130137758 Akt activity specifically inhibiting polypeptide |
| 05/30/2013 | US20130137637 Peptides for promoting angiogenesis and an use thereof |
| 05/30/2013 | US20130137631 Gip analog and hybrid polypeptides with selectable properties |
| 05/30/2013 | US20130137603 Newly identified colon cancer marker and diagnostic kit using the same |
| 05/30/2013 | US20130137106 Tumor Marker and Methods of Use Thereof |
| 05/30/2013 | US20130136742 Peptide having cell membrane penetrating activity |
| 05/29/2013 | EP2596799A1 Methods and compositions related to inhibition of viral entry |
| 05/29/2013 | EP2596124A1 Novel substrates the fluorescence of which is suppressed, preparation thereof, and use thereof for identifying, detecting, and assaying legionella pneumophilia |
| 05/29/2013 | EP2596009A1 Peptides based on the transmembrane domain of a toll-like receptor (tlr) for treatment of tlr-mediated diseases |
| 05/29/2013 | EP2595496A1 Antimicrobial peptide, branched forms thereof and their use in the treatment of bacteria infections |
| 05/29/2013 | CN103122031A Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 05/29/2013 | CN103122023A Purification method for triptorelin |
| 05/29/2013 | CN103122022A Angiotensin converting enzyme inhibitory peptide derived from bitter almond protein and preparation method thereof |
| 05/29/2013 | CN102492022B Novel anti-senile dementia lead compound |
| 05/29/2013 | CN102260325B Antibacterial peptide NX-16, and preparation method and application thereof |
| 05/29/2013 | CN102174081B Method for preparing eptifibatide and precursor thereof |
| 05/29/2013 | CN102167728B 改进的胃泌素释放肽化合物 Improved gastrin-releasing peptide compounds |
| 05/28/2013 | US8450454 Compositions for inhibiting ABAD/ABeta protein interaction |
| 05/28/2013 | US8450283 Composition for treating cancer and use thereof |
| 05/28/2013 | US8450280 Activation of peptide prodrugs by hK2 |
| 05/28/2013 | US8450247 Cell display libraries |